翻訳と辞書 |
Keith Flaherty : ウィキペディア英語版 | Keith Flaherty
Keith Flaherty is director of Developmental Therapeutics at the Massachusetts General Hospital Cancer Center and associate professor of medicine at Harvard Medical School.〔(Keith T. Flaherty, MD - Massachusetts General Hospital, Boston, MA )〕 He was previously a professor of medicine at the University of Pennsylvania. He is known for his research on targeted therapies for cancer, and in particular for his work on the melanoma drug vemurafenib.〔(Target Cancer - A Roller Coaster Chase for a Cure - Series - NYTimes.com )〕〔(Target Cancer - After Long Fight, Melanoma Drug Gives Sudden Reprieve - Series - NYTimes.com )〕〔(Target Cancer - A Drug Trial Cycle - Recovery, Relapse, Reinvention - Series - NYTimes.com )〕〔(Inhibition of Mutated, Activated BRAF in Metastatic Melanoma — NEJM )〕 In 2013, Massachusetts General Hospital partnered with AstraZeneca to partner Flaherty's research into developing a formula to identify vulnerabilities of tumors with AstraZeneca's library of drugs. ==References==
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Keith Flaherty」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|